 |
|
 |
 |
| |
News -> July, 1999 News
The American Rhinologic Society Corporate Affiliates Committee met
in Palm Desert in May with a banquet honoring our commercial
supporters of the Society. We are once again pleased to report
that the Corporate Affiliates contributed $47,000 to the Society
for 1999, bringing total contributions to date to $180,000.
| The contributors for 1999 are as follows: |
| GlaxoWellcome, Inc. |
Platinum ($10,000) |
| Schering-Plough Pharmaceuticals |
Platinum ($10,000) |
| Bristol-Myers Squibb Co. |
Gold ($5,000) |
| Hoechst Marion Roussel |
Gold ($5,000) |
| Karl Storz Endoscopy |
Gold ($5,000) |
| Xomed Surgical Products |
Gold ($5,000) |
| Rhone Poulenc Rorer |
Silver ($2,500) |
| Ortho-McNeil Pharmaceuticals |
Bronze ($1,000) |
| Surgical Laser Technologies |
Bronze ($1,000) |
| Visualization Technology |
Bronze ($1,000) |
| Abbott Laboratories |
Friends of our Society ($500) |
| Linvatec |
Friends of our Society ($500) |
| Richard Wolf Medical Instruments |
Friends of our Society ($500) |
We will honor our 1999 Corporate members with a certificate of
affiliation, which will be given the them at the New Orleans
fall meetings. A substantial portion of these funds has already
been designated for research grants in rhinology. The next
deadline for application for rhinology research grants will be
March 1, 2000, with grants awarded by July 1, 2000.
Members should also note the unrestricted educational grants from
Schering-Plough, SmithKline Beecham and Astra that have underwritten
publication of this Newsletter over the past year.
Paul H. Toffel, M.D.
University of Southern California
Department of Otolaryngology
Glendale,California
|
|
|
|
|
